102 related articles for article (PubMed ID: 28933097)
1. [Pharmacokinetics and brain distribution of NMD/TMP-nanoparticles].
He WJ; Hong Q; Liang J; He XW; Zhu FJ
Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(22):4254-4258. PubMed ID: 28933097
[TBL] [Abstract][Full Text] [Related]
2. Preparation, preliminary pharmacokinetics and brain tissue distribution of Tanshinone IIA and Tetramethylpyrazine composite nanoemulsions.
Wang B; Hong L; Liu Y; Bedingfield SK; Zhang C; Peng C; Qian J; Zha L
Pharm Dev Technol; 2019 Dec; 24(10):1236-1242. PubMed ID: 31407940
[No Abstract] [Full Text] [Related]
3. TAT-modified serum albumin nanoparticles for sustained-release of tetramethylpyrazine and improved targeting to spinal cord injury.
Lin Y; Wan Y; Du X; Li J; Wei J; Li T; Li C; Liu Z; Zhou M; Zhong Z
J Nanobiotechnology; 2021 Jan; 19(1):28. PubMed ID: 33478501
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.
Chalikwar SS; Belgamwar VS; Talele VR; Surana SJ; Patil MU
Colloids Surf B Biointerfaces; 2012 Sep; 97():109-16. PubMed ID: 22609590
[TBL] [Abstract][Full Text] [Related]
5. Effect of ferulic acid on the brain pharmacokinetics of tetramethylpyrazine in conscious rats.
Wu Y; Liao F; Liao W; Yu J; Deng X; Zheng H; Meng Y; Wang L
Xenobiotica; 2017 Nov; 47(11):973-979. PubMed ID: 27827094
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oral bioavailability of acetylpuerarin by poly(lactide-co-glycolide) nanoparticles optimized using uniform design combined with response surface methodology.
Sun D; Xue A; Zhang B; Xue X; Zhang J; Liu W
Drug Des Devel Ther; 2016; 10():2029-39. PubMed ID: 27382256
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
8. Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration.
Miyazawa T; Nakagawa K; Harigae T; Onuma R; Kimura F; Fujii T; Miyazawa T
Int J Nanomedicine; 2015; 10():7223-30. PubMed ID: 26664113
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization.
Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, and in vivo study of rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral delivery.
Yuan Z; Gu X
Drug Des Devel Ther; 2015; 9():2301-9. PubMed ID: 25960633
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
12. Comparative Pharmacokinetics of Nimodipine in Rat Plasma and Tissues Following Intraocular, Intragastric, and Intravenous Administration.
Li F; Fei Q; Mao D; Si Q; Dai M; Ma Q; Zhang H; Bai L; He N
AAPS PharmSciTech; 2020 Aug; 21(6):234. PubMed ID: 32794077
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
[TBL] [Abstract][Full Text] [Related]
14. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting.
Md S; Ali M; Baboota S; Sahni JK; Bhatnagar A; Ali J
Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles.
Liu M; Li H; Luo G; Liu Q; Wang Y
Arch Pharm Res; 2008 Apr; 31(4):547-54. PubMed ID: 18449515
[TBL] [Abstract][Full Text] [Related]
17. In vivo microdialysis with ultra performance liquid chromatography-mass spectrometry for analysis of tetramethylpyrazine and its interaction with borneol in rat brain and blood.
Liao W; Huang X; Yin Y; Liu B; Zhu R
Biomed Chromatogr; 2018 Jun; 32(6):e4210. PubMed ID: 29431191
[TBL] [Abstract][Full Text] [Related]
18. Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes.
Kalam MA; Alshamsan A
Biomed Pharmacother; 2017 Oct; 94():402-411. PubMed ID: 28772219
[TBL] [Abstract][Full Text] [Related]
19. [Effects of tetramethylpyrazine on pharmacokinetics in plasma and brain dialysate and neuropathic pain in rat model of spared sciatic nerve injury].
Chen Z; DU DD; Gao Y; Chen JM; Wei CP; Weng XG; Sun J; Wang XY; Wang ZG; Zhang MY
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(6):1632-1640. PubMed ID: 38621948
[TBL] [Abstract][Full Text] [Related]
20. Depot injectable biodegradable nanoparticles loaded with recombinant human bone morphogenetic protein-2: preparation, characterization, and in vivo evaluation.
Hassan AH; Hosny KM; Murshid ZA; Alhadlaq A; Alyamani A; Naguib G
Drug Des Devel Ther; 2015; 9():3599-606. PubMed ID: 26203226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
